Skip to content
zameds

Gabapentin Pharma-q

Active ingredient not listed in the SAHPRA register

Pharma-q Holdings (Pty) Ltd

Registration

Applicant
Pharma-q Holdings (Pty) Ltd
Registrations
5

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Gabapentin 600 MG tablets pharma-q600 mgTablets48045648/2.5/0456RegisteredNot determinedNone
Gabapentin 800 MG tablets pharma-q800 mgTablets48045748/2.5/0457RegisteredNot determinedNone
Gabapentin 100 MG capsules pharma-q100 mgCapsules48060248/2.5/0602RegisteredNot determinedNone
Gabapentin 300 MG capsules pharma-q300 mgCapsules48060348/2.5/0603RegisteredNot determinedNone
Gabapentin 400 MG capsules pharma-q400 mgCapsules48060448/2.5/0604RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

No structure available

The SAHPRA register lists no active ingredient for this product, so there is no compound to show.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles